Second-Line Bismuth-Containing Quadruple Therapy for <i>Helicobacter</i><i>pylori</i> Infection: A 12-Year Study of Annual Eradication Rates

Second-Line Bismuth-Containing Quadruple Therapy for <i>Helicobacter</i><i>pylori</i> Infection: A 12-Year Study of Annual Eradication Rates

Background: Bismuth-containing quadruple therapy (BQT) consisting of a proton-pump inhibitor (PPI), bismuth, metronidazole and tetracycline is recommended as a second-line treatment for <i>Helicobacter pylori</i> (<i>H. pylori</i>) infection when PPI-based standard triple the...

Full description

Bibliographic Details
Main Authors: Kiwon Shin, Min-Jae Cho, Jung-Hwan Oh, Chul-Hyun Lim
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Journal of Clinical Medicine
Subjects:
bismuth
breath test
duration of therapy
eradication
<i>Helicobacter pylori</i>
Online Access:https://www.mdpi.com/2077-0383/10/15/3273

Internet

https://www.mdpi.com/2077-0383/10/15/3273

Similar Items